HCQ in Resectable Localized Prostate Cancer

NCT06408298 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Resectable Localized Prostate Cancer

Interventions

DRUG: Hydroxychloroquine Sulfate 400Mg Tab
DRUG: Placebo

Sponsor

Lionel.D.Lewis, MD

Collaborators

[object Object]